20 May 2013
Keywords: entremed, gets, go-ahead, phase, trial, angiostatin, food
Article | 03 February 2000
The US Food and Drug Administration has approved a Phase Idose-escalating human trial of EntreMed's experimental cancer drug
angiostatin, and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 February 2000
4 February 2000
2 February 2000
© 2013 thepharmaletter.com